TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Quanterix ( (QTRX) ) has provided an announcement.
On November 20, 2025, Quanterix Corporation announced significant leadership changes to support its next phase of growth. Paul Meister and David Walt retired from the Board of Directors, while Garret Hampton and Alan Sachs were appointed as new members. Additionally, Bill Donnelly was named Executive Chair, and Jeffrey Elliott was appointed Lead Independent Director. These changes aim to strengthen Quanterix’s strategic initiatives, including expanding its biomarker menu and accelerating growth following the Akoya acquisition. The Board now comprises nine members, with a focus on advancing the company’s mission to improve health outcomes.
The most recent analyst rating on (QTRX) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Quanterix stock, see the QTRX Stock Forecast page.
Spark’s Take on QTRX Stock
According to Spark, TipRanks’ AI Analyst, QTRX is a Neutral.
Quanterix’s overall stock score reflects significant financial challenges, with negative profitability and cash flow issues being the most impactful factors. While the earnings call showed positive revenue growth and strategic integration, ongoing market weaknesses and valuation concerns weigh heavily on the score.
To see Spark’s full report on QTRX stock, click here.
More about Quanterix
Quanterix is a global leader in ultra-sensitive biomarker detection, enabling breakthroughs in disease research, diagnostics, and drug development. Its proprietary Simoa® technology allows researchers to detect and quantify biomarkers at concentrations far below traditional limits. The company recently expanded its portfolio by acquiring Akoya Biosciences, enhancing its capabilities in multiplexed tissue imaging with single-cell resolution.
Average Trading Volume: 558,080
Technical Sentiment Signal: Sell
Current Market Cap: $273.7M
Learn more about QTRX stock on TipRanks’ Stock Analysis page.